Clinical trial Recruiting at 1 site Interventional Ages 21 to 64

Improving antidepressant adherence in primary care patients

Official title: Antidepressant Medication Adherence in Adults With Depression

Run by University of Pennsylvania · NCT06496646 · Data updated 2026-11-12

This study is testing whether sending personalized daily text messages, with or without cash rewards, can help people with depression stick to their antidepressant medication better than regular care.

Quick facts

Study typeInterventional
Ages21 Years to 64 Years
SexAll
Enrollment525 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedMarch 19, 2025
Main results expectedMarch 31, 2029
Study endsMarch 31, 2029
Registry record updatedNovember 26, 2025
Trial IDNCT06496646 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 to 64 with a clinical diagnosis of major depressive disorder who are newly prescribed antidepressants.

Probably not a fit

Patients with a history of treatment for bipolar disorder or schizophrenia, or those with active substance use disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial aims to compare different strategies for supporting medication adherence among primary care patients diagnosed with depression who have recently been prescribed antidepressants. The study will evaluate the effectiveness of personalized daily text messages, with and without financial incentives, against standard care in improving adherence and reducing depression symptoms. Adherence will be monitored using a wireless pill bottle and participants will report their depression symptoms via telephone assessments at 6 and 12 weeks. The primary outcome will be measured using the PHQ-9 depression rating scale.

Why it matters

Potential benefit: If successful, this study could enhance medication adherence and improve depression symptoms for patients in primary care settings.

How similar studies have gone: Previous studies have shown that text message reminders can improve medication adherence, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Penn Medicine primary care outpatients
* Clinical diagnosis of major depressive disorder
* A score of 10+ on the Patient Health Questionnaire 9 (PHQ-9)
* Age 21 to 64 years at the time of study entry
* Prescribed an antidepressant by their primary care clinician
* Express interest in taking antidepressant medication
* Own a cell phone
* Capable of using the electronic pill bottle
* English-speaking

Exclusion Criteria:

* Treated with antidepressants in the past 90 days
* Pregnant or breastfeeding
* An active substance use disorder other than nicotine
* A lifetime history of treatment for bipolar disorder or schizophrenia
* Hospital admission or emergency department visit for suicidal symptoms in the past year
* Lack capacity to provide informed consent
* Using antidepressant more than 10 days at baseline assessment

Where it's running

  • University of Pennsylvania Health System
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.